Programme

Programme is subject to change.

Please click here to download abstracts for oral presentations.

Please click here to download abstracts for PHARMAC Award presentations.

Please click here to download abstracts for poster presentations.


Thursday 23 August

 2.00pm - 5.00pm

Registration open

 2.00pm - 4.00pm

Networking site pack in

 6.00pm - 8.00pm
Welcome function
1876 Restaurant and Bar


Friday 24 August

 7.00am - 5.30pm
Registration desk open


7.30am - 9.00am

MSD Breakfast symposium
Immune checkpoint inhibition in the clinic
Chair: Dr Richard North, Tauranga Hospital
Dr Catherine Barrow, Capital & Coast District Health Board
Dr Tony Rahman, Canterbury District Health Board


 9.00am

Conference opening

Session one: Cancer Biomarkers

 9.30am

Chair introduction
Dr Anita Dunbier

 9.40am


Liquid biopsies: Monitoring the cancer genome in blood
Associate Professor Sarah-Jane DawsonPeter MacCallum Cancer Centre

 10.20am


Long non-coding RNAs as drivers of tumor progression and metastasis
Dr Sarah Diermeier, University of Otago

 10.40am

A common variation in the IL6 promoter predicts time to metastasis for colorectal cancer and may indicate the mechanisms involved
Dr Nicholas Fleming, University of Otago

 10.50am

Proteomic analysis of breast cancer brain metastasis microenvironment in-vivo reveals a unique  milieu intérieur of metabolic reprogramming
Dr Priyakshi Kalita-de Croft, University of Queensland


 11.00am

Morning tea


Session two: Management and ethics of tissue banking

 11.20am

Chair introduction
Dr Margaret Currie

 11.30am

The Stanford Biobank: Standardisation and innovation for next generation biobanking
Dr Rohit Gupta, Stanford Biobank

 12.10pm

Barriers to indigenous peoples participation in bio banking and genomic research
Associate Professor Jonathan Koea, Waitemata District Health Board

 12.30pm Merkel Cell Polyomavirus status and outcome for Merkel Cell Carcinoma in a New Zealand cohort
Kate Parker, University of Auckland


 12.40pm


Lunch

Session three: PHARMAC Awards

  Session chairs
Dr Kate Clarke and Dr Nicholas Fleming

 1.15pm

Development of plasma genomic biomarkers for mutation detection and monitoring in New Zealand cancer patients
Sandra Fitzgerald, University of Auckland

  Unmet need for patients with cancer admitted to hospital under non-oncology services: need for an integrated acute oncology/palliative care service?
Dr Nadia Hitchen, Auckland City Hospital

  Investigating the clinical significance of fibroblast growth factor inducible 14 in breast cancer
Joshua Harris, University of Otago

  Early WBCC experiences with check-point inhibitors in advanced melanoma - Response rates, toxicity, and the effect of baseline ECOG status
Dr Jessica Lowe, Wellington Blood and Cancer Centre 

  Evaluating variants in breast cancer associated genes identified by panel sequencing of New Zealand breast cancer patients
Dr Vanessa Lattimore, University of Otago, Christchurch

  Real-world palliative chemotherapy use and outcomes – A national view from the pharmaceutical claims collection
Dr Johanna Paddison, PHARMAC

  The role of Pseudokinase TRIB1 in breast cancer
Hamish McMillan, University of Otago

  Engineering a 3D model system for studying breast cancer-adipocyte interactions within the tumour microenvironment
Jessika Wise, University of Otago, Christchurch


 2.30pm

Afternoon tea


Session four: Patient focussed cancer diagnosis and treatment

 3.00pm

Chair introduction
A/Prof Michael Jameson

 3.10pm

Neuroendocrine tumours - cracking the epigenetic code
Dr Christina Thirlwell, UCL Cancer Institute, University College London

 3.50pm


Orientation of newly diagnosed cancer patients:  Improving patient empowerment, equity, and various outcomes, while saving clinicians' time 
Dr Heather Heron-Speirs, Psychologist

 4.10pm


Bruce Cain Memorial Lecture
Professor Bridget Robinson, University of Otago, Christchurch

 4.45pm - 5.45pm

Poster session with drinks and canapes


 6.30pm onwards


50th anniversary conference dinner at Skyline



Saturday 25 August

 8.30am - 3.30pm Registration desk open
 

Session five: Molecular oncology

Session kindly supported by Maurice Wilkins Centre

 9.00am

Chair introduction
Dr Ben Lawrence

 9.10am

US National Cancer Institute Precision Medicine Initiatives: NCI-MATCH and Beyond
Dr James Doroshow, National Cancer Institute, USA


 9.50am

Co-targeting BRAF and VEGF-A receptors synergistically inhibited the growth of BRAF-mutant and BRAF wild-type melanomas
Khanh Tran, University of Auckland

 10.00am

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer
Dr Yan Li, University of Auckland

 10.10am

Targeting DNA-dependent protein kinase for tumour-selective radiosensitisation
Professor Bill Wilson, University of Auckland

 10.20am

A History of the New Zealand Society for Oncology
Cheryl Ware


 10.40am

Morning tea


Session six: New technologies in cancer research

 11.10am

Chair introduction
Dr Sharon Pattison

 11.20am


Optical barcoding highlights novel characteristics of treatment resistant cells in metastatic colorectal cancer
Associate Professor Frederic Hollande, University of Melbourne

 12.00pm

The importance of digital technologies in research and innovation
Dr Helen Lunt, Canterbury District Health Board
 12.20pm

An increase in effector Tregs is a classifying feature of the immune landscape in colorectal tumours
Dr Sam Norton, University of Otago

 12.30pm

Investigating Tumour Evolution in a Single Patient with disseminated disease
Tamsin Robb, University of Auckland

 12.40pm

Survival after Breast Conserving Surgery (BCS) Compared to Mastectomy (MTX) in Early Stage Breast Cancer
Shoaib Abrahimi, University of Auckland


 12.50pm


Lunch


Session seven: Mechanisms for translational cancer research

 1.40pm

Chair introduction
A/ Prof Roslyn Kemp

 1.50pm


Molecular mechanisms governing sensitivity and resistance to epigenetic therapies
Professor Mark Dawson, Peter MacCallum Cancer Centre

 2.30pm

Presentation of NZSO Translational Researcher Award

 2.35pm

NZSO Translational Researcher Award Lecture
Teaching old drugs new tricks
Associate Professor Michael Jameson, Waikato Hospital

 3.00pm


2017 Roche Translational Cancer Research Fellowship recipient presentation
Dr Francis Hunter, University of Auckland

 3.10pm

Conference close


 3.30pm

NZSO AGM



Sunday 26 August

Joint NZASI session at Rydges Hotel

  

NZSO will be held immediately prior to Queenstown Research Week in 2018. There are several interesting satellite meetings and we hope that NZSO delegates would consider staying on a few extra days to attend other meetings. As part of our collaborative plan, we are offering NZSO delegates free attendance at an "Onoc-Immunology" session on the morning of Sunday 26 August at the NZASI (Immunology) QRW meeting. Delegates may also be interested in QRW- Cancer. See details on QRW website here for more info.

Please note that other than complimentary attendance at the NZASI Onco-Immunology session, QRW runs as a separate and distinct event from NZSO. If you plan to attend a full QRW meeting, you will need to register for both NZSO on this website and QRW satellite meetings here.

 

Contacts

Roslyn KempNZSO President

Kate ClarkeVice President

Ken Dempster NZSO Membership

Charlotte Emery Conference and Website